Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) has 179 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 17,687,772 | 0 | 0.00% | $63,322,224.00 |
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 17,687,772 | 0 | 0.00% | $62,084,080.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 8,544,423 | 1,652,219 | 23.97% | $29,990,925.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 7,906,071 | 791,700 | 11.13% | $27,750,309.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 7,834,795 | -71,276 | -0.90% | $28,048,565.00 |
| Citigroup Inc | 31 Mar, 2026 | 5,246,349 | 5,235,924 | 50,224.69% | $18,414,685.00 |
| Citigroup Inc | 31 Mar, 2026 | 5,107,708 | -138,641 | -2.64% | $18,285,595.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 4,690,215 | 4,690,215 | 0.00% | $16,790,970.00 |
| State Street Corp | 31 Mar, 2026 | 4,485,989 | 2,785,358 | 163.78% | $16,059,841.00 |
| Morgan Stanley | 31 Mar, 2026 | 3,941,377 | 294,338 | 8.07% | $13,834,233.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,775,736 | 3,775,736 | 0.00% | $13,517,135.00 |
| MAVERICK CAPITAL LTD | 31 Mar, 2026 | 3,567,372 | 1,054,262 | 41.95% | $12,771,192.00 |
| Newtyn Management, LLC | 31 Mar, 2026 | 3,165,900 | 515,900 | 19.47% | $11,333,922.00 |
| Nuveen, LLC | 31 Mar, 2026 | 3,128,753 | 2,970,741 | 1,880.07% | $11,200,936.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 3,118,124 | 1,333,203 | 74.69% | $11,162,884.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,069,930 | 2,366,402 | 336.36% | $10,990,350.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 3,038,715 | 3,012,368 | 11,433.44% | $10,878,600.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,992,735 | -850,598 | -22.13% | $10,504,500.00 |
| Monaco Asset Management SAM | 31 Mar, 2026 | 2,987,296 | 95,035 | 3.29% | $10,485,409.00 |
| Newtyn Management, LLC | 31 Mar, 2026 | 2,650,000 | 147,137 | 5.88% | $9,301,500.00 |